After a study participant died from a severe and rare inflammatory syndrome, the FDA placed a partial clinical hold on a France-based drugmaker’s cancer drug trial.
St. Luke’s Duluth (Minn.) saw its long-term rating on a series of bonds lowered to “BB+” from “BBB-” amid weaker balance sheet metrics, S&P Global said Oct. 5.
Cleveland-based University Hospitals entered into a 10-year partnership with GE HealthCare to implement new technologies across its radiology practice and at its UH Harrington Heart & Vascular Institute.
Tacoma, Wash.-based MultiCare Health System had ratings on a series of bonds downgraded to “A” from “A+” on Oct. 5 amid balance sheet deterioration, S&P Global said.